Goldman Sachs
AMAG

Goldman Sachs’s AMAG Pharmaceuticals AMAG Stock Holding History

Goldman Sachs’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-40,000
Closed -$1.28M – 7404
2014
Q3 		$1.28M Buy
40,000
+4,200
+12% +$89.6K ﹤0.01% 4366
2014
Q2 		$742K Buy
+35,800
New +$662K ﹤0.01% 4981
2014
Q1 		– Sell
-15,000
Closed -$364K – 6993
2013
Q4 		$364K Buy
+15,000
New +$353K ﹤0.01% 5543

Goldman Sachs's AMAG Position: Q4 2020 in Review

Goldman Sachs sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,021,177 shares — an estimated $19M sold.

Goldman Sachs first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $25.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Goldman Sachs reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Goldman Sachs sold 2,021,177 AMAG Pharmaceuticals shares in Q4 2020, an estimated $19M.
  • Goldman Sachs first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
  • Goldman Sachs's AMAG Pharmaceuticals position peaked at $25.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.